OMER Return on Tangible Equity | OMEROS CORP

OMEROS CORP (OMER) Return on Tangible Equity

2026-06-30: Return Tang Equity -243.09%.
2026-03-31: Return Tang Equity -136.06%.
2025-12-31: Return Tang Equity 2.76%.
2025-09-30: Return Tang Equity 54.95%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-243.09%
2026-03-31	-136.06%
2025-12-31	2.76%
2025-09-30	54.95%
2025-06-30	53.56%
2025-03-31	71.69%
2024-12-31	85.87%
2024-09-30	87.26%
2024-06-30	112.40%
2024-03-31	170.05%
2023-12-31	471.57%
2023-09-30	-143.26%
2023-06-30	196.40%
2023-03-31	85.06%
2022-12-31	55.34%
2022-09-30	-430.33%
2022-06-30	-593.41%
2022-03-31	-3986.07%
2021-12-31	816.80%
2021-09-30	47.07%
2021-06-30	56.61%
2021-03-31	64.93%
2020-12-31	114.33%
2020-09-30	148.88%
2020-06-30	66.98%
2020-03-31	67.62%
2019-12-31	77.50%
2019-09-30	56.32%
2019-06-30	78.15%
2019-03-31	100.02%
2018-12-31	126.56%
2018-09-30	134.58%
2018-06-30	155.93%
2018-03-31	234.28%
2017-12-31	1900.53%
2017-09-30	-614.07%
2017-06-30	114.94%
2017-03-31	127.40%
2016-12-31	178.24%
2016-09-30	293.95%
2016-06-30	148.79%
2016-03-31	188.91%
2015-12-31	286.25%
2015-09-30	843.88%
2015-06-30	-937.83%
2015-03-31	-346.52%
2014-12-31	172.72%
2014-09-30	206.12%
2014-06-30	474.49%
2014-03-31	-881.60%
2013-12-31	216.47%
2013-09-30	191.21%
2013-06-30	367.91%
2013-03-31	252.38%
2012-12-31	588.64%
2012-09-30	4989.15%
2012-06-30	166.27%
2012-03-31	243.63%
2011-12-31	513.97%
2011-09-30	-627.32%
2011-06-30	-265.79%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	2.76%
2024-12-31	85.87%
2023-12-31	471.57%
2022-12-31	55.34%
2021-12-31	816.80%
2020-12-31	114.33%
2019-12-31	77.50%
2018-12-31	126.56%
2017-12-31	1900.53%
2016-12-31	178.24%
2015-12-31	286.25%
2014-12-31	172.72%
2013-12-31	216.47%
2012-12-31	588.64%
2011-12-31	513.97%
2010-12-31	-142.90%
2009-12-31	-48.88%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
Oric Pharmaceuticals, Inc. (ORIC)	United States	$1.367B	-8.00
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
Kardigan, Inc. (KARD)	United States	$1.346B
Tyra Biosciences, Inc. (TYRA)	United States	$1.337B	-12.83
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82